Patent details

EP3052132 Title: ANTIBODY THERAPIES FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV)

Basic Information

Publication number:
EP3052132
PCT Application Number:
US2014058383
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148470040
PCT Publication Number:
WO2015048770
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY THERAPIES FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV)
French Title of Invention:
TRAITEMENTS PAR ANTICORPS POUR LE VIRUS DE L'IMMUNODÉFICIENCE HUMAINE (VIH)
German Title of Invention:
ANTIKÖRPERTHERAPIEN FÜR DEN HUMANEN IMMUNDEFIZIENZVIRUS (HIV)
SPC Number:

Dates

Filing date:
30/09/2014
Grant date:
29/07/2020
EP Publication Date:
10/08/2016
PCT Publication Date:
02/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/07/2020
EP B1 Publication Date:
29/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/09/2020
Expiration date:
30/09/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2020
 
 

Name:
Beth Israel Deaconess Medical Center, Inc.
Address:
330 Brookline Avenue, Boston, MA 02215, United States (US)

Inventor

Name:
BAROUCH, Dan, H.
Address:
United States (US)

Priority

Priority Number:
201361884414 P
Priority Date:
30/09/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/21; A61K 39/42; C12N 5/07;

Publication

European Patent Bulletin

1

Issue number:
202031
Publication date:
29/07/2020
Description:
Grant (B1)

2

Issue number:
202123
Publication date:
09/06/2021
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages